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Abstract
The use of a medical guideline can be seen as the execution of compu-
tational tasks, sequentially or in parallel, in the face of patient data. It
has been shown that many of such guidelines can be represented as a
‘network of tasks’, i.e., as a number of steps that have a specific func-
tion or goal. To investigate the quality of such guidelines we propose
a formalization of criteria for good practice medicine a guideline should
comply to. We use this theory in conjunction with medical background
knowledge to verify the quality of a guideline dealing with diabetes mel-
litus type 2 using the interactive theorem prover KIV. Verification using
task execution and background knowledge is a novel approach to quality
checking of medical guidelines.
1 Introduction
Computer-based decision support in health-care is a field with a long stand-
ing tradition, dealing with complex problems in medicine, such as diagnosing
disease and prescribing treatment. The trend of the last decades has been to
base clinical decision making more and more on sound scientific evidence, i.e.,
evidence-based medicine [15]. In practice this has led medical specialists to de-
velop evidence-based medical guidelines, i.e., structured documents providing
detailed steps to be taken by health-care professionals in managing the disease
in a patient, for promoting standards of medical care.
Researchers in Artificial Intelligence have picked up on these developments
and are working on providing computer-based support for guidelines by design-
ing computer-oriented languages and developing tools for their deployment. In
[4, 11] the emergence of a new paradigm is acknowledged for modelling complex
clinical processes as a ‘network of tasks’, which model tasks as a number of steps
that have a specific function or goal. Examples of languages that support task
modelling are PROforma [4] and Asbru [14], which have been evolving since
the 1990s. Medical guidelines are considered to be good real-world examples of
highly structured documents amenable to formalisation.
However, guidelines should not be considered static objects as new scientific
knowledge becomes known on a continuous basis. Newly obtained evidence may
result in a deterioration of guideline quality, because, for example, new patient
management options invalidate the steps recommended by the guideline. Our
aim, therefore, is to provide support for verifying quality criteria of medical
guidelines in light of scientific evidence.
We approach this problem by applying formal methods to quality check
medical guidelines. Here, we are mainly concerned with the meta-level approach
[7], i.e., verifying general principles of good practice medicine as for example
advocated by the General Medical Council [6]. For example, a guideline of good
quality should preclude the prescription of redundant drugs, or advise against
the prescription of treatment that is less effective than some alternative. For
the verification of such quality criteria, the medical knowledge the guideline is
based on, i.e., knowledge based on available evidence, is required. We will refer
to this knowledge as background knowledge.
The structure of this paper is as follows. First, we model the background
knowledge concerning the treatment of diabetes mellitus type 2. Then, the
advises, given by the guideline as formalised as a ‘network of tasks’ using the
language Asbru, are modelled. Finally, meta-level properties for this model
are formalised and verified in KIV, an interactive theorem prover. To the best
of our knowledge, verification of a fully formalised guideline, as a network of
tasks, using medical background knowledge has not been done before.
2 Medical Guidelines
Clinical practice guidelines are systematically developed statements to assist
practitioners and patients decisions about appropriate health care in specific
clinical circumstances. A fragment of a guideline is shown in Figure 1, which
is part of the guideline for general Dutch practitioners about the treatment of
diabetes mellitus type 2 [13], and is used as a running example in this paper.
The guideline contains recommendations for the clinical management in daily
practice. Each of these recommendations is well-founded in terms of scientific
evidence obtained from the literature, in conjunction with other considerations
such as safety, availability, or cost effectiveness.
The diabetes mellitus type 2 guideline provides practitioners with a clear
structure of recommended interventions to be used for the control of the glucose
level. This kind of information is typically found in medical guidelines in the
sense that medical knowledge is combined with information about order and
time of treatment (e.g., a sulfonylurea drug at step 2), and about patients and
their environment (e.g., quetelet index lower than or equal to 27).
Although diabetes mellitus type 2 is a complicated disease, the guideline
fragment shown in Figure 1 is not. This indicates that much knowledge con-
cerning diabetes mellitus type 2 is missing from the guideline and that ad-
ditional knowledge is needed for verifying whether the guideline fulfils some
property. The ideas that we use here for verifying quality requirements for
– Step 1: diet.
– Step 2: if quetelet index (QI) ≤ 27, prescribe a sulfonylurea (SU) drug;
otherwise, prescribe a biguanide (BG) drug.
– Step 3: combine a sulfonylurea (SU) and biguanide (BG) drug (replace
one of these by a α-glucosidase inhibitor if side-effects occur).
– Step 4: one of the following:
• oral antidiabetic and insulin
• only insulin
Figure 1: Guideline fragment on diabetes mellitus type 2 management. If one
of the steps k is ineffective, the management moves to step k + 1.
medical guidelines are inspired by [7], where a distinction was made between
the different types of knowledge that are involved in defining quality require-
ments. We assume that there are at least three types of knowledge involved in
detecting the violation of good practice medicine:
1. Knowledge concerning the (patho)physiological mechanisms underlying
the disease, and the way treatment influences these mechanisms (back-
ground knowledge).
2. Knowledge concerning the recommended treatment in each stage of the
plan and how the execution of this plan is affected by the state of the
patient (order information from the guideline).
3. Knowledge concerning good practice in treatment selection (quality re-
quirements).
In the following sections we describe these three types of knowledge in more
detail, give a formalisation of all three parts, and verify the requirements.
3 Formalisation of Medical Guidelines
It has been shown previously that the step-wise, possibly iterative, execution
of a guideline can be described precisely by means of temporal logic [9]. In this
paper we will use the variant of this logic supported by KIV [1], which is based
on linear temporal logic. The language used is first-order logic, augmented
with the usual modal operators 2 and 3. With 2ϕ being true if ϕ is true in
the current state and all future states, and 3ϕ if ϕ holds in the current state
or in some state in the future. We also use a special operator last which is
true exactly if there does not exist a future point in time. Additional modal
operators are supported by KIV, but they are not used in this article. Algebraic
specifications are used in KIV to model the datatypes.
3.1 Background knowledge
In diabetes mellitus type 2 various metabolic control mechanisms are deranged
and many different organ systems may be affected. Glucose level control, how-
ever, is the most important mechanism. At some stage in the natural history
of diabetes mellitus type 2, the level of glucose in the blood is too high (hy-
perglycaemia) due to decreased production of insulin by the B cells. Oral
anti-diabetics either stimulate the B cells in producing more insulin (sulfony-
lurea) or inhibit the release of glucose from the liver (biguanide). Effectiveness
of these oral diabetics is dependent on the condition of the B cells. Finally,
as a causal treatment, insulin can be prescribed. The mechanisms have been
formalised in terms of a first-order predicate knowledge:
knowledge : patient× patient
where patient denotes an algebraic specification of all first-order formulas de-
scribing the patient state, e.g., condition(hyperglycaemia) represents those pa-
tients having a condition of hyperglycaemia. The postfix function [·] on patients
selects the value for a certain variable from the state, e.g., Patient[‘condition′]
= hyperglycaemia if and only if condition(hyperglycaemia) holds for this pa-
tient. The predicate knowledge represents the state transitions that may occur
between patient states, i.e., the first argument (denoted by pre below) rep-
resents the current patient state and the second argument (denoted by post
below) represents the next patient state.
The predicate knowledge has been axiomatised with knowledge concerning
the mechanism described above. The axiomatisation is a direct translation of
an earlier formalisation in temporal logic [7] of which two examples are:
BDM2-1:
knowledge(pre, post) →
(insulin ∈ pre[‘treatment’] →




(post[‘uptake(liver,glucose)’] = up ∧
post[‘uptake(peripheral-tissue,glucose)’] = up) ∧
pre[‘capacity(B-cells,insulin)’] = exhausted ∧
pre[‘condition’] = hyperglycaemia
→ post[‘condition’] = normoglycaemia)
The axiom BDM2-1 denotes the physiological effects of insulin treatment,
i.e., administering insulin results in an increased uptake of glucose by the liver
and peripheral tissues. Axiom BDM2-8 phrases under what conditions you may
expect the patient to get cured, i.e., when the patient suffers from hypergly-
caemia and insulin production of his B cells are exhausted, an increased uptake
of glucose by the liver and peripheral tissues results in the patient condition
changing to normoglycaemia.
3.2 Medical guidelines in Asbru
Much research has already been devoted to the development of representation
languages for medical guidelines. Most of them consider guidelines as a com-
position of actions, controlled by conditions [10]. However, most of them are
not formal enough for the purpose of our research as they often incorporate
free-text elements which do not have a clear semantics. Exceptions to this are
PROforma [4] and Asbru [14]. The latter has been chosen in our research.
In Asbru, plans are hierarchically organised in which a plan refers to a num-
ber of sub-plans. The overall structure of the Asbru model of our running exam-
ple (Figure 1), is shown in Figure 2. The top level plan Treatments and Control
sequentially executes the four sub-plans Diet, SU or BG, SU and BG, and In-
sulin Treatments, which correspond to the four steps of the guideline fragment
in Figure 1. The sub-plan Insulin Treatments is further refined by two sub-plans




Insulin TreatmentsSU and BGSU or BG
Figure 2: Asbru plan hierarchy of the diabetes mellitus type 2 guideline
The Asbru specifications of two plans in the hierarchy, namely SU or BG
and Insulin Treatments are defined as follows:
plan SU or BG
effects
(QI ≤ 27 → SU ∈ Drugs) ∧
(QI > 27 → BG ∈ Drugs)
abort condition
condition = hyperglycaemia confirmation required
complete condition
condition = hypoglycaemia ∨
condition = normoglycaemia
plan Insulin Treatments
body anyorder wait for one
Insulin and Antidiabetics
Insulin
In the case of SU or BG there is a relationship between the quetelet index
(QI) and the drug administered. If the quetelet index is less or equal than
27 then SU is administered, else BG is administered. The plan SU or BG cor-
responds to step 2 in the guideline fragment of Figure 1, which completes if
the patient condition improves, i.e., the patient no longer has hyperglycaemia.
This is represented by the complete condition. The plan SU or BG aborts
when the condition of the patient does not improve, which is represented by
the abort condition. It requires a manual confirmation to ensure that some
time passes for the drugs to have an impact on the patient condition.
The plan Insulin Treatments consists of two sub-plans, which correspond to
the two options of step 4 in the guideline fragment of Figure 1, i.e., either
insulin is administered or insulin and antidiabetics are administered.
3.3 Quality requirements
Here, we give a formalisation of good practice medicine of medical guidelines.
This extends previous work [7], which formalised good practice medicine on the
basis of a theory of abductive reasoning of single treatments. The context of the
formalisation given here is a fully formalised guideline, which consists, besides
a number of treatments, of a control structure that uses patient information to
decide on a particular treatment. This contrast with [7], which used a context
of a singly chosen treatment.
Firstly, we formalise the notion of a proper guideline according to the theory
of abductive reasoning. Let B be medical background knowledge, P be a patient
group, N be a collection of intentions, which the physician has to achieve, and
M be a medical guideline. Then M is called a proper guideline for a patient
group P , denoted as M ∈ PrP , if:
(M1) B ∪M ∪P 6|= ⊥ (the guideline does not have contradictory effects), and
(M2) B ∪ M ∪ P |= 3N (the guideline eventually handles all the patient
problems intended to be managed)
Secondly, we formalise good practice medicine of guidelines. Let ¹ϕ be a
reflexive and transitive order denoting a preference relation with M ¹ϕ M
′
meaning that M ′ is at least as preferred to M given criterion ϕ. With ≺ϕ we
denote the order such that M ≺ϕ M
′ if and only if M ¹ϕ M
′ and M ′ 6¹ϕ M .
When both M ¹ϕ M
′ and M ′ ¹ϕ M hold or when M and M
′ are incomparable
w.r.t. ¹ϕ we say that M and M
′ are indifferent, which is denoted as M ∼ M ′.
If in addition to (M1) and (M2) condition (M3) holds, with
(M3) Oϕ(M) holds, where Oϕ is a meta-predicate standing for an optimality
criterion or combination of optimality criteria ϕ defined as: Oϕ(M) ≡
∀M ′ ∈ PrP : ¬(M ≺ϕ M
′),
then the guideline is said to be in accordance with good practice medicine w.r.t.
criterion ϕ and patient group P , which is denoted as Goodϕ(M,P ).
A typical example for Oϕ is consistency of the recommended treatment
order w.r.t. a preference relation ¹ψ over treatments, i.e., Oϕ(M) holds if the
guideline M recommends treatment T before treatment T ′ when T ′ ≺ψ T holds.
For example, in diabetes mellitus type 2, a preference relation over treatments
would be to minimise (1) the number of insulin injections, and (2) the number
of drugs involved. This results, among others, in the following preferences:
sulfonylurea drug ∼ biguanide drug, and insulin ¹ψ insulin and antidiabetic
¹ψ sulfonylurea and biguanide drug ¹ψ sulfonylurea or biguanide drug ¹ψ
diet. A guideline M would then be in accordance with good practice medicine
if it is consistent with this preference order ¹ψ, e.g., if M first recommends
diet before a sulfonylurea or biguanide drug.
4 Verification using KIV
The formal verification was done with the interactive verification tool KIV [1].
A speciality of KIV is the use of primed and double-primed variables: a primed
variable V ′ represents the value of this variable after a system transition, the
double-primed variable V ′′ is interpreted as the value after an environment
transition, where the environment transition models the communication of the
system with its environment. System and environment transitions alternate,











Figure 3: The relation between unprimed and primed variables as two tran-
sitions: the system transition (including the Asbru model and its effects) and
the environment transition (including the background knowledge)
With the help of KIV, we have verified that the diabetes guideline is proper,
i.e., that the guideline satisfies conditions (M1) and (M2), which is discussed in
Subsections 4.1 and 4.2. Furthermore, with KIV we have verified various meta-
level quality requirements of the diabetes mellitus type 2 guideline. Each meta-
level quality requirement is verified using a sequent Γ ` Σ where the succedent Σ
is some instantiation of (M3) and the antecedent Γ consists of the initial state
of a patient group, the initial state of the guideline, the medical guideline,
effects of treatment plans, the background knowledge, and the environment
assumptions, which is shown in Figure 4. The verification of two meta-level
requirements are discussed in Subsections 4.3 and 4.4.
AS[‘tc’] = inactive, . . ., /* Initial state of guideline */
[inactive#(‘tc’, ‘st’;AS,Patient)], /* Asbru plan */
2(AS[‘SU or BG’] = activated ↔ /* Effects */
BG ∈ Patient′[‘treatment’] ∧ . . .),
2knowledge(Patient′, Patient′′) /* Background knowledge */
2(AS′′[‘tc’] = AS′[‘tc’] ∧ . . .) /* Environment assumption */
Figure 4: Antecedent of proof obligations with tc shorthand for Treat-
ments and Control and AS an additional data structure of type asbru-state,
which keeps track of all plan states over time, in which initially each plan
is set to inactive.
4.1 Consistency of background knowledge
Property (M1) ensures that the formal model including the Asbru guideline
and the background knowledge is consistent. The initial state is – in our case
– described as a set of equations and it has been trivial to see that they are
consistent. The guideline is given as an Asbru plan. The semantics of any Asbru
plan is defined in a programming language where every program construct
ensures that the resulting reactive system is consistent: in every step, the
program either terminates or calculates a consistent output for arbitrary input
values. The Asbru plan, thus, defines a total function between unprimed and
primed variables in every step (Figure 3). The formula defining the effects maps
the output variables of the guideline to input variables of the patient model.
Again, it has been trivial to see that this mapping is consistent.
The background knowledge defines our patient model. We consider the
patient to be part of the environment which is the relation between the primed
and the double primed variables in every step. If the patient model ensures
that for an arbitrary primed state there exists a double primed state, the overall
system of alternating guideline and environment transitions is consistent: given
an initial (unprimed) state, the guideline calculates an output (primed) state;
the effects define a link between the variables of the guideline and the variables
of the patient model; the patient model reacts to the (primed) output state and
gives a (double primed) state which is again input to the Asbru guideline in the
next step. In other words, the relation between the unprimed and the double
primed state is the complete state transition. The additional environment
assumptions referring to the Asbru environment do not destroy consistency as
the set of restricted variables of the environment assumption is disjunct to the
set of variables of the patient model.
It remains to ensure consistency of the background knowledge which we
defined as a predicate knowledge. Consistency can be shown by proving the
property
∀pre. ∃post. knowledge(pre, post)
which ensures that the relation is total. In order to prove that this property
holds an example patient has been constructed. Verifying that the example
patient is a model of the background knowledge has been fully automatic.
4.2 Successful treatment
In order to verify property (M2), i.e., the guideline eventually manages to con-
trol the glucose level in the patient’s blood, a proof has been constructed. The
verification strategy in KIV is symbolic execution with induction [1]. The plan
state model introduced in [2] defines the semantics of the different conditions of
a plan and is implemented in KIV by a procedure called asbru, which is symbol-
ically executed. Each plan can be in a certain state, modelled with a variable
AS (i.e., inactive, considered, ready, activated, and aborted (or completed)) and a
transition to another state depends on its conditions. In the initial state, the
top level plan Treatments and Control (abbreviated tc) is in inactive state. After
executing the first step, the plan is considered, after which execution continues
as described in [2]. The execution is visualised in a proof tree (cf. Figure 5),
where the bottom node is the start of the execution and splits if there is a case
distinction.
Patients whose capacity of the B cells is normal are cured with diet, while
for other patients diet will not be sufficient. In this case, we assume that the
doctor eventually aborts the diet treatment. We use induction to reason about
the unspecified time period in which diet is applied. As an invariant,
Patient[‘capacity(B-cells,insulin)’] 6= normal
is used. In the next step, the doctor has either aborted diet or diet is still
active. In the second case, induction can be applied. When diet is aborted, tc
sequentially executes the next plan, which is SU or BG (cf. Figure 2).
The second treatment SU or BG goes, as each Asbru plan, through a se-
quence of states, i.e., inactive, considered, ready, activated, and aborted, and thus
becomes first considered and after some steps becomes activated (cf. Figure 5).
In this case, either SU or BG is prescribed, depending on the quetelet index
QI. For a patient whose B cell capacity is subnormal, the background knowledge
ensures that the condition of the patient improves. Thus, for the rest of the
proof we can additionally assume that
Patient[‘capacity(B-cells,insulin)’] 6= subnormal
After SU or BG aborts, the third treatment (SU and BG) is executed in similar
fashion, where patients with nearly exhausted B cell capacity are cured. Thus,
after aborting the first three treatments the precondition concerning the B cell
capacity can be strengthened to
Patient[‘capacity(B-cells,insulin)’] 6= normal
∧ Patient[‘capacity(B-cells,insulin)’] 6= subnormal
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Figure 5: Overview of the proof that the guideline eventually manages all
patient problems, which is explained in Section 4.2.
which, under the assumption that the only possible values of the capacity are
normal, subnormal, nearly-exhausted, and exhausted, yields:
Patient[‘capacity(B-cells,insulin)’] = exhausted
This statement together with the background knowledge ensures that the pre-
scription of insulin, which is prescribed in both final treatments Insulin and
Insulin and Antidiabetics, finally cures the patient.
4.3 Optimality of treatment
With respect to property (M3), an optimality criterion of the guideline is that
no treatments are prescribed that are not in accordance with good practice
medicine (Section 3.3), i.e., some preference relation ¹ between treatments
exists and the guideline never prescribes a treatment T such that T ¹ T ′ and
T ′ cures the patient group under consideration.
In our case study the preference for treatments is based on the minimisation
of (1) the number of insulin injections, and (2) the number of drugs involved
(cf. Section 3.3). We have defined this using a reflexive, transitive order ≤ such
that for all treatments T , it holds that insulin ≤ T and T ≤ diet. Furthermore,
the treatments prescribing the oral anti-diabetics sulfonylurea and biguanide
are incomparable. The proof obligation is then as follows:
2(∀T :Good≤(T, Patient) → T ≤ Patient[‘treatment’])
where Good≤(T, Patient) denotes that T is a treatment according to good
practice medicine for Patient, as defined in [8]. To prove this, the following
axiom was added to the system:
2Patient[‘QI’] = Patient′′[‘QI’]
i.e., the quetelet index does not change during the run of the protocol. This
axiom is needed, because the decision of prescribing a treatment is not exactly
at the same time as the application of the treatment and therefore the deci-
sion of prescribing this treatment could be based on a patient with a different
quetelet index than the patient that actually takes the drugs.
Proving this property in KIV was done in approximately 1 day using several
heuristics for the straightforward parts. The theorem was proven using two
lemmas for two specific patient groups. In total, it took approximately 500
steps, of which nearly 90% were done automatically, to verify this property.
4.4 Order of treatments
Finally, another instance of (M3) was proven. This property phrases that the
order of any two treatments in the protocol is consistent with the order relation
as we have defined in Subsection 3.3. In other words, in case a patient may
receive multiple treatments, the less radical treatments are tried first. The
formalisation of the property in KIV was done as follows:
2∀T (Tick ∧ T = Patient[‘treatment’]
→ 2(last ∨ (Tick → ¬(T ≤ Patient[‘treatment’]))))
At each time, the current treatment is bound to a static variable (i.e.,
unchanged by symbolic execution) T , which can be used to compare against
subsequent steps in the protocol. For any future steps, we require that either
the protocol completes (last holds) or that activated treatments are not more
preferred than T . The additional Tick variable is needed in the formalisation
to abstract from technical system steps.
This property also had a high degree of automation with roughly 800 steps
in total. The reason for this slightly higher number of steps is due to nested
temporal operators.
5 Discussion
As the interest in medical guidelines continues to grow, there is a need for
criteria to asses the quality of medical guidelines. An important method for
the appraisal of medical guidelines was introduced by the AGREE collaboration
[3]. A solid foundation for the application of formal methods to the quality
checking of medical guidelines, using simulation of the guideline [4, 12] and
theorem proving techniques [9], can also be found in literature.
In [9], logical methods have been used to analyse properties of guidelines,
formalised as task networks. In [8], it was shown that the theory of abduc-
tive diagnosis can be taken as a foundation for the formalisation of quality
requirements of a medical guideline in temporal logic. This result has been
used to verify quality requirements of good practice medicine of treatments [7].
However, in the latter work, the order between treatment depending on the
condition of the patient and previous treatments was ignored. In this paper,
we consider elements from both approaches by including medical background
knowledge in the verification of complete networks of tasks. This required a
major change to the previous work with respect to the formulation of quality
criteria, because quality is now defined with respect to a complete network of
tasks instead of individual treatments as presented in [8].
Compared to previous work concerning the verification of networks of tasks,
the meta-level approach we have presented here has a number of advantages.
In the meta-level approach, quality is defined independently of domain specific
knowledge, and, consequently, proof obligations do not have to be extracted
from external sources. One successful attempt of the latter was reported in
[5], where quality criteria are formalised on the basis of instruments to monitor
the quality of care in practice, i.e., medical indicators. Firstly, the question is
whether these indicators, based on compliance with medical guidelines, coincide
with the quality of the guideline itself. Secondly, it has been our experience
that it is far from easy to find suitable properties in external sources, because
these sources may not be completely applicable, e.g., typically, other guide-
lines may address different problem in the management of the same disease.
Thirdly, many useful quality criteria of guidelines are implicit, making this ap-
proach fundamentally limiting. In this sense, the meta-level approach provides
a more systematic method for the formulation of proof obligations and, thus,
verification of medical guidelines.
In summary, in this study we have setup a general framework for the verifica-
tion of medical guidelines, consisting of a medical guideline, medical background
knowledge, and quality requirements. A model for the background knowledge
of glucose level control in diabetes mellitus type 2 patients was developed based
on a general temporal logic formalisation of (patho)physiological mechanisms
and treatment information. Furthermore, we developed a theory for quality
requirements of good practice medicine based on the theory of abductive diag-
nosis. This model of background knowledge and theory of quality requirements
were then used in a case study in which we verified several quality criteria of
the diabetes mellitus type 2 guideline used by the Dutch general practitioners.
In the case study we use Asbru to model the guideline as a network of tasks
and KIV for the formal verification.
In the course of our study we have shown that the general framework that we
have setup for the formal verification of medical guidelines with medical back-
ground knowledge is feasible and that the actual verification of quality criteria
can be done with a high degree of automation. We believe both the inclusion of
medical background knowledge and task networks to be necessary elements for
adequately supporting the development and management of medical guidelines.
An important advantage of using theorem proving compared to alternative
techniques such as model checking is that it provides insight in the proof struc-
ture. For each case, it is relatively easy to inspect the proof tree and to find out
the reason that a certain quality criterion holds. On the other hand, KIV is a
tool with a very expressive logic, which may result in an additional overhead
when verifying quality criteria of medical guidelines. It is clear that tools for
quality checking earlier on in the development process of a guideline, where
such an additional overhead is not acceptable, would be useful. Therefore, also
techniques such as model checking will be a topic for future research.
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